SCHEMBL24528655

SCHEMBL24528655

CN(C)CCCC/N=C/c1ccc(-c2nc(-c3ccccc3)c3ccn(-c4ccc(/C=N/CCCCN(C)C)cc4)c3n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 2/20 0.33
LMNA P02545 1/20 0.33
TLR9 Q9NR96 3/20 0.33
RAD52 P43351 2/20 0.32
POLB P06746 2/20 0.32
THRB P10828 1/20 0.32
NPY1R P25929 1/20 0.32
NPY2R P49146 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PDE4B Q07343 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30
ACP1 P24666 1/20 0.30
NUDT1 P36639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24528599 0.99 KDM4E (0.33) KDM4EALDH1A1MAPK1ATMLMNA
SCHEMBL24528695 0.97 KDM4E (0.34) KDM4EALDH1A1MAPK1ATMLMNA
SCHEMBL24528677 0.96 KDM4E (0.34) KDM4EALDH1A1MAPK1LMNATLR9
SCHEMBL29681045 0.96 KDM4E (0.37) KDM4EALDH1A1MAPK1ATMLMNA
SCHEMBL24528596 0.96 KDM4E (0.37) KDM4EALDH1A1MAPK1ATMLMNA
SCHEMBL29680746 0.94 KDM4E (0.37) KDM4EALDH1A1MAPK1ATMLMNA
SCHEMBL24528512 0.94 KDM4E (0.37) KDM4EALDH1A1MAPK1ATMLMNA
SCHEMBL24528652 0.93 KDM4E (0.32) KDM4EALDH1A1LMNAPDE4B
SCHEMBL24528627 0.88 ALDH1A1 (0.36) KDM4EALDH1A1RAD52POLB
SCHEMBL24528689 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022129376-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-06-23 WO disclosed